We are live on
!
Find out more
HMC
Harvard Management Company Portfolio holdings
AUM
$1.82B
1-Year Est. Return
26.23%
This Fund
S&P 500
This Quarter
Est. Return
+28.13%
1 Year Est. Return
+26.23%
3 Year Est. Return
+156.3%
5 Year Est. Return
+133.98%
10 Year Est. Return
+221.37%
AUM
$952M
AUM Growth
+$145M
(+18%)
Cap. Flow
-$15.2M
Cap. Flow
% of AUM
-1.6%
Top 10 Holdings %
Top 10 Hldgs %
83.36%
Holding
48
New
2
Increased
–
Reduced
2
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UiPath
PATH
|
+$1.04M |
| 2 |
El Pollo Loco
LOCO
|
+$514K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Revolution Medicines
RVMD
|
+$8.74M |
| 2 |
Pliant Therapeutics
PLRX
|
+$8.01M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Communication Services | 51.57% |
| 2 | Consumer Discretionary | 16.94% |
| 3 | Technology | 16.01% |
| 4 | Healthcare | 11.54% |
| 5 | Industrials | 2.42% |
Similar funds
DWT
MCC
ST
DE
SI
WIC
GC
RHJA
Harvard Management Company's Q1 2023 Portfolio in Review
As of Q1 2023, Harvard Management Company held 48 positions worth $952M, up 18% from $807M the previous quarter. Its ten largest holdings account for 83% of the portfolio.
Trading was light in Q1 2023: portfolio turnover was 4.2%. Harvard Management Company opened 2 new positions and made no exits, leaving the 48-position portfolio largely intact.
By sector, the portfolio is most concentrated in Communication Services at 52% of assets, up from 43% a quarter earlier, followed by Consumer Discretionary and Technology.
- Harvard Management Company's largest Q1 2023 buy was UiPath: 69,073 shares worth $1.21M.
- Harvard Management Company's biggest Q1 2023 reduction was Revolution Medicines, cutting an estimated $8.74M.
- Harvard Management Company's ten largest holdings make up 83% of its $952M portfolio in Q1 2023.
- Harvard Management Company opened 2 new positions and closed 0 in Q1 2023.
- Harvard Management Company's portfolio value rose 18% quarter-over-quarter to $952M.
Based on Harvard Management Company's 13F filing for Q1 2023, filed 15 May 2023.